did fda ban semaglutide Compounded & Tirzepatide 2025: Safe Use Guide U.S. FDA finds no evidence
Description
Plaintiffs may argue that the warning was dropped not because uncertainty was resolved, but because it was deprioritized as prescriptions surged and use expanded beyond the populations originally studied

The discussion drew on over a decade of Virtas experience prescribing, managing, and deprescribing GLP-1s and covered everything from long-term efficacy and deprescription to benefit design, cost management, and the future of GLP-1 access
Novo Nordisk, the maker of Ozempic and Wegovy, told CBS News that the drugs "are a well-established class of medicines, which have demonstrated long-term safety in clinical trials

The Role of Continuous GLP-1 Therapy in Weight Maintenance Continuous semaglutide use maintains the appetite-suppression pathway active, allowing your brain to sustain satiety signaling without constant willpower battles

This is a different category entirely from general supplements

In particular, the JAK/STAT molecular pathway has emerged as a key target in the evolving therapeutic landscape for HS
